Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruo Inokuchi

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 18, 2015
[Recent progress in radiation therapy]Masahiro Hiraoka, Haruo Inokuchi
Nagoya Journal of Medical Science|January 9, 2025
Risk-adapted stereotactic body radiation therapy delivered in four fractions in patients with non-small cell lung cancerYutaka Masuoka, Takuhito Tada, Shogo Matsuda, et al.
Lung|December 22, 2007
Clinical outcome of stage III non-small-cell lung cancer patients after definitive radiotherapyTatsuya Nakamura, Nobukazu Fuwa, Takeshi Kodaira, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2009
The impact of radiation dose and fractionation on outcomes for limited-stage small-cell lung cancerNatsuo Tomita, Takeshi Kodaira, Toyoaki Hida, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practiceHaruo Inokuchi, Takashi Mizowaki, Yoshiki Norihisa, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2008
Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapyTakeshi Kodaira, Natsuo Tomita, Hiroyuki Tachibana, et al.
Practical Radiation Oncology|July 6, 2023
Long-Term Outcomes of a Prospective Study on Highly Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer for 3 WeeksKiyonao Nakamura, Itaru Ikeda, Haruo Inokuchi, et al.
International Journal of Clinical Oncology|July 31, 2017
Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidanceKiyonao Nakamura, Takashi Mizowaki, Haruo Inokuchi, et al.
International Journal of Clinical Oncology|July 13, 2015
Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinomaHaruo Inokuchi, Takashi Mizowaki, Yoshiki Norihisa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 3, 2008
Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinomaTakeshi Kodaira, Nobukazu Fuwa, Toru Nakanishi, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 18, 2015
[Recent progress in radiation therapy]Masahiro Hiraoka, Haruo Inokuchi
Nagoya Journal of Medical Science|January 9, 2025
Risk-adapted stereotactic body radiation therapy delivered in four fractions in patients with non-small cell lung cancerYutaka Masuoka, Takuhito Tada, Shogo Matsuda, et al.
Lung|December 22, 2007
Clinical outcome of stage III non-small-cell lung cancer patients after definitive radiotherapyTatsuya Nakamura, Nobukazu Fuwa, Takeshi Kodaira, et al.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2009
The impact of radiation dose and fractionation on outcomes for limited-stage small-cell lung cancerNatsuo Tomita, Takeshi Kodaira, Toyoaki Hida, et al.
Clinical and Translational Radiation Oncology|March 30, 2018
Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practiceHaruo Inokuchi, Takashi Mizowaki, Yoshiki Norihisa, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2008
Aichi cancer center initial experience of intensity modulated radiation therapy for nasopharyngeal cancer using helical tomotherapyTakeshi Kodaira, Natsuo Tomita, Hiroyuki Tachibana, et al.
Practical Radiation Oncology|July 6, 2023
Long-Term Outcomes of a Prospective Study on Highly Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer for 3 WeeksKiyonao Nakamura, Itaru Ikeda, Haruo Inokuchi, et al.
International Journal of Clinical Oncology|July 31, 2017
Decreased acute toxicities of intensity-modulated radiation therapy for localized prostate cancer with prostate-based versus bone-based image guidanceKiyonao Nakamura, Takashi Mizowaki, Haruo Inokuchi, et al.
International Journal of Clinical Oncology|July 13, 2015
Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinomaHaruo Inokuchi, Takashi Mizowaki, Yoshiki Norihisa, et al.
International Journal of Radiation Oncology, Biology, Physics|June 3, 2008
Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinomaTakeshi Kodaira, Nobukazu Fuwa, Toru Nakanishi, et al.
Pageof 4